Predictmedix AI Inc. (CSE:PMED)

Predictmedix AI Balance Sheet

Financials in millions CAD. Fiscal year is February - January.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 31, 2025	Jan 31, 2025	Jan 31, 2024	Jan 31, 2023	Jan 31, 2022	Jan 31, 2021
Cash & Equivalents	0.31	-	0.04	0.08	0.21	0.48
Cash & Short-Term Investments	0.31	-	0.04	0.08	0.21	0.48
Cash Growth	-	-	-53.47%	-62.49%	-55.98%	-67.86%
Accounts Receivable	-	-	-	0.01	0.17	-
Other Receivables	0.11	0.05	0.01	0.03	0.21	0.11
Receivables	0.11	0.05	0.01	0.04	0.38	0.11
Prepaid Expenses	0.01	0.02	0.02	0.02	0.05	0.16
Total Current Assets	0.43	0.07	0.07	0.14	0.64	0.75
Property, Plant & Equipment	0.05	0.07	0.09	0.13	0.08	0.01
Other Intangible Assets	-	-	0.32	0.45	0.52	0.25
Total Assets	0.49	0.13	0.48	0.72	1.24	1
Accounts Payable	1.29	1.32	0.56	0.83	0.33	0.14
Short-Term Debt	-	-	-	0.04	-	-
Current Unearned Revenue	-	-	-	-	0.02	-
Other Current Liabilities	-	0.13	0.06	-	-	-
Total Current Liabilities	1.29	1.45	0.63	0.87	0.35	0.14
Total Liabilities	1.29	1.45	0.63	0.87	0.35	0.14
Common Stock	7.99	7.48	7.48	6.26	5.72	4.03
Retained Earnings	-12.03	-11.25	-10.08	-8.08	-6.02	-4.13
Comprehensive Income & Other	3.24	2.45	2.45	1.67	1.19	0.97
Total Common Equity	-0.8	-1.32	-0.14	-0.15	0.89	0.87
Shareholders' Equity	-0.8	-1.32	-0.14	-0.15	0.89	0.87
Total Liabilities & Equity	0.49	0.13	0.48	0.72	1.24	1
Total Debt	-	-	-	0.04	-	-
Net Cash (Debt)	0.31	-	0.04	0.04	0.21	0.48
Net Cash Growth	-	-	-10.89%	-80.42%	-55.98%	-67.53%
Net Cash Per Share	0.00	-	0.00	0.00	0.00	0.00
Filing Date Shares Outstanding	206.79	192.53	150.26	135.14	109.05	108.8
Total Common Shares Outstanding	194.53	150.26	150.26	122.05	109.05	101.72
Working Capital	-0.85	-1.39	-0.56	-0.73	0.29	0.61
Book Value Per Share	-0.00	-0.01	-0.00	-0.00	0.01	0.01
Tangible Book Value	-0.8	-1.32	-0.46	-0.6	0.37	0.62
Tangible Book Value Per Share	-0.00	-0.01	-0.00	-0.00	0.00	0.01
Machinery	0.19	0.19	0.19	0.19	0.1	0.01

Updated Oct 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.